Pliant Therapeutics Announces Pricing of Initial Public Offering

Pliant Therapeutics Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., June 2, 2020 /PRNewswire/ — Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the pricing of its initial public offering of 9,000,000…


Read Full Article